A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2011
10/12/2011	EP2374878A2 Novel adamts-13 mutant
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2374788A1 Indanyl compounds
10/12/2011	EP2374779A1 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
10/12/2011	EP2374508A1 Combination of angiotension receptor blockers (ARB) and NSAIDs for use in ameliorating cachexia
10/12/2011	EP2374458A1 Combination of an ACE inhibitor and an NSAID for use in ameliorating cachexia/SIRS
10/12/2011	EP2374455A2 Modulators of muscarinic receptors
10/12/2011	EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	EP1487482B1 Dna vaccine against proliferating endothelial cells and methods of use thereof
10/12/2011	EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011	EP1294377B1 Methods and compositions for the treatment of alcoholism and alcohol dependence
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216316A Substituted amine derivative and medicinal composition comprising same as the active ingredient
10/12/2011	CN102216310A Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210802A Traditional Chinese medicine for treating postpartum night sweat
10/12/2011	CN102210800A New application of citron daylily and citron daylily general flavone
10/12/2011	CN102210782A Compound traditional Chinese medicine for treating glucocorticoid dependence and application thereof
10/12/2011	CN102210759A Application of Chinese medicinal component in preparation of nitric oxide donor medicament
10/12/2011	CN102210756A Chinese medicinal preparation for treating postpartum paralysis of sows
10/12/2011	CN102210630A System and method for preparing nosiheptide premix particles
10/12/2011	CN101336929B Medicine for increasing intra-abdominal pressure
10/12/2011	CN101306185B Traditional Chinese medicine taken orally for treating damp-heat depression-steam type bromidrosis
10/12/2011	CN101185683B Cream shape medicine for treating infantile sweatful symptoms
10/12/2011	CN101160139B Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2
10/11/2011	US8035016 Method of using gold nanorods-siRNA complexes
10/11/2011	US8034981 Modified bio-related substance, process for producing the same, and intermediate
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034904 First therapeutic agent is an antibody or an epitope-binding fragment having the same amino acid sequence as the murine antibody EM164 produced by mouse hybridoma EM164; a second therapeutical agent selected from carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel etc.; anticarcinogenic agents
10/11/2011	US8034814 Phthalazine derivatives with angiogenesis inhibiting activity
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	US8034804 (Pyrido/thieno)-[f]-oxazepine-5-one derivatives
10/11/2011	US8034775 Kallikrein-inhibitor therapies
10/11/2011	US8034772 Inhibitor of vascular endothelial cell growth factor
10/11/2011	US8034343 Methods of treating inflammatory disorders of the lungs
10/11/2011	CA2560781C Synthetic membrane anchors
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/11/2011	CA2494235C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2493872C Accelerating agent for elimination of dioxins
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.
10/11/2011	CA2457027C Chitin microparticles and their medical uses
10/11/2011	CA2454665C Modifying the fatty acid composition of cell membranes of organs and tissues
10/11/2011	CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
10/11/2011	CA2447663C Composition and use of substances for the stabilization of sulphur-containing amino acids
10/11/2011	CA2447538C Cellular signal-responsive gene transcriptional regulation system
10/11/2011	CA2442151C Stable solution of reduced coenzyme q
10/11/2011	CA2420537C A composition for treatment of parkinson's disease
10/11/2011	CA2400482C Bupropion metabolites and methods of their synthesis and use
10/11/2011	CA2393410C Phosphonate compounds
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/11/2011	CA2325442C Treatment of cardiac hypertrophy using interferon-gamma
10/11/2011	CA2247275C Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/06/2011	WO2011123858A2 Ccn3 peptides and analogs thereof for therapeutic use
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011122468A1 Pyripyropene derivative having acat2 inhibiting activity and stable to metabolizing enzymes
10/06/2011	WO2011122458A1 Aromatic ring compound containing nitrogen
10/06/2011	WO2011122321A1 Agent for inhibiting physiological activity of heparin-binding protein
10/06/2011	WO2011122041A1 Expression modulator for clock gene period
10/06/2011	WO2011122040A1 Expression modulator for clock gene bmal
10/06/2011	WO2011121354A1 The therapeutic use of tetrathiomolybdate
10/06/2011	WO2011121109A1 Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
10/06/2011	US20110245501 Substituted Tetracycline Compounds as Synergistic Antifungal Agents
10/06/2011	US20110245337 Method for enhancing the dna repair process, treating disorders associated with the dna repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
10/06/2011	US20110245332 Injectable formulations of taxanes for cad treatment
10/06/2011	US20110245326 Post-Transcriptional Regulation Of RNA-Related Processes Using Encoded Protein-Binding RNA Aptamers
10/06/2011	US20110245320 Nuclease resistant double-stranded ribonucleic acid
10/06/2011	US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011	US20110245305 Pharmaceutical compositions for poorly soluble drugs
10/06/2011	US20110245270 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/06/2011	US20110245254 Heterocyclic compounds as inhibitors of beta-lactamases
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245243 Compounds and compositions as cathepsin s inhibitors
10/06/2011	US20110245216 Use of dhea derivatives for enhancing physical performance
10/06/2011	US20110245214 Organic compounds
10/06/2011	US20110245202 Pharmaceutical composition for the treatment of rhinitis
10/06/2011	US20110245158 High Protein Supplement
10/06/2011	US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244446 Rna sequence-specific mediators of rna interference
10/06/2011	US20110244064 composition for the treatment of hypertension
10/06/2011	US20110244032 Dispersible phospholipid stabilized microparticles
10/06/2011	US20110244028 Method of solubilizing biologically active compounds
10/06/2011	US20110244023 Transdermal delivery patch
10/06/2011	US20110244014 Implantable medical articles having laminin coatings and methods of use
10/06/2011	US20110243968 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
10/06/2011	US20110243954 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243919 Compositions and Methods for Treating Collagen-Mediated Diseases
10/06/2011	US20110243914 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/06/2011	US20110243909 Compositions and Methods for Treating Collagen-Mediated Diseases
10/06/2011	US20110243908 Compositions and Methods for Treating Collagen-Mediated Diseases
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243859 Encapsulating system for cest imaging with chelate q greater than or equal to 2
10/06/2011	US20110243858 Hydroxylated contrast enhancement agents and imaging method
10/06/2011	US20110243854 Methods and systems for identifying modulators of longevity

1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 1564